1061 Does Medicare Advantage Reimbursement Underpay for Spine Fusions Compared to Commercial Insurance?

INTRODUCTION: Inpatient, elective thoracolumbar spine fusions are among the most expensive major surgical classes in US Healthcare. Private insurers now provide half of Medicare reimbursement through privately run, publicly funded Medicare Advantage (MA) insurance plans. It is largely unknown how MA reimbursement compares to the commercial reimbursement that hospitals rely upon to stay in business. METHODS: A cross-sectional study was undertaken comparing price transparency data for spine hospitals across the US using Turquoise Health’s website and cross-referenced with the latest available Medicare Hospital Cost Report and the Healthcare Cost Institute’s Healthy Market Index (HMI) for Hospital Competition. Each hospital’s website was studied and excluded if noncompliant with the Price Transparency Law’s mandate to provide patient-facing price transparency data. Hospitals with both MA and commercial reimbursement rates were included. Median negotiated MA and commercial reimbursements for each hospital were compared. RESULTS: Out of 779 thoracolumbar fusion (DRG 460) capable hospitals, 330 (42%) had patient-facing price estimates on their websites and provided reimbursement data for both MA and commercial reimbursement. MA reimbursement was significantly lower (Median $28,136, Q1:$25,861, Q3:$32,449) vs. commercial reimbursement (Median $45,960, Q1:$33,264, Q3:$62,378, p<0.001). This rate difference did not differ based on hospital market competition. On average, the MA reimbursement was 39% lower than commercial reimbursement at the same hospitals. CONCLUSIONS: For inpatient elective thoracolumbar spine fusions, Medicare Advantage significantly underpays compared to commercial insurance. This is a significant finding given the rapid growth in Medicare Advantage over the last several years. Further studies are needed to discern the underlying. Given future bundled payments and risk of complication with deformity and scoliosis surgery, further studies are needed to discern the underlying impact of Medicare reimbursement on hospital finances with resepect to adult spinal deformity surgery.

Authors

Publication Details

Journal
Neurosurgery
Published
2025-03-14
DOI
https://doi.org/10.1227/neu.0000000000003360_1061
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

1061 Does Medicare Advantage Reimbursement Underpay for Spine Fusions Compared to Commercial Insurance?

Campbell Liles, Alan R. Tang, Mason Alford, Anthony E. Bishay et al.
Neurosurgery
Health Systems, Economic Evaluations, Quality of Life
article

1061 Does Medicare Advantage Reimbursement Underpay for Spine Fusions Compared to Commercial Insurance?

Campbell Liles, Alan R. Tang, Mason Alford, Anthony E. Bishay, Robert J. Dambrino, Austin J. Triana, John Edwards Dugan, Lola B. Chambless, Gunther Wong, Scott L. Zuckerman, Emma Ye
article en

Abstract

INTRODUCTION: Inpatient, elective thoracolumbar spine fusions are among the most expensive major surgical classes in US Healthcare. Private insurers now provide half of Medicare reimbursement through privately run, publicly funded Medicare Advantage (MA) insurance plans. It is largely unknown how MA reimbursement compares to the commercial reimbursement that hospitals rely upon to stay in business. METHODS: A cross-sectional study was undertaken comparing price transparency data for spine hospitals across the US using Turquoise Health’s website and cross-referenced with the latest available Medicare Hospital Cost Report and the Healthcare Cost Institute’s Healthy Market Index (HMI) for Hospital Competition. Each hospital’s website was studied and excluded if noncompliant with the Price Transparency Law’s mandate to provide patient-facing price transparency data. Hospitals with both MA and commercial reimbursement rates were included. Median negotiated MA and commercial reimbursements for each hospital were compared. RESULTS: Out of 779 thoracolumbar fusion (DRG 460) capable hospitals, 330 (42%) had patient-facing price estimates on their websites and provided reimbursement data for both MA and commercial reimbursement. MA reimbursement was significantly lower (Median $28,136, Q1:$25,861, Q3:$32,449) vs. commercial reimbursement (Median $45,960, Q1:$33,264, Q3:$62,378, p<0.001). This rate difference did not differ based on hospital market competition. On average, the MA reimbursement was 39% lower than commercial reimbursement at the same hospitals. CONCLUSIONS: For inpatient elective thoracolumbar spine fusions, Medicare Advantage significantly underpays compared to commercial insurance. This is a significant finding given the rapid growth in Medicare Advantage over the last several years. Further studies are needed to discern the underlying. Given future bundled payments and risk of complication with deformity and scoliosis surgery, further studies are needed to discern the underlying impact of Medicare reimbursement on hospital finances with resepect to adult spinal deformity surgery.

NeurosurgeryVol. 71(Supplement_1)
Openalex Percentile: Top 93%
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.